Surgery Partners (SGRY) FCF Margin (2014 - 2026)
Surgery Partners' (SGRY) quarterly FCF Margin came in at 4.42% in Q2 2026, down 259.0% year-over-year from 2.78% in Q2 2025, and up 933.05% quarter-over-quarter from 0.53% in Q1 2026.
Analysis
Surgery Partners (SGRY) FCF Margin (2014 - 2026) Analysis & Trends
Surgery Partners has disclosed FCF Margin across 13 years of filings, most recently posting 4.42% for Q2 2026.
- In Q2 2026, FCF Margin fell 259.0% year-over-year to 4.42%; the TTM figure through Jun 2026 stood at 5.57% (up 16.0% YoY), while the FY2025 annual figure was 5.91%, down 82.0% from the prior year.
- FCF Margin came in at 4.42% for Q2 2026 at Surgery Partners, up from 0.53% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 12.71% in Q3 2023 to a low of 2.19% in Q4 2022.
- Average FCF Margin over 5 years is 5.35%, with a median of 5.83% recorded in 2024.
- Year-over-year, FCF Margin surged 1072 bps in 2023 and sank 687 bps in 2024.
- Over 5 years, FCF Margin stood at 2.19% in 2022, then surged by 366 bps to 5.82% in 2023, then jumped by 77 bps to 10.31% in 2024, then retreated by 1 bps to 10.24% in 2025, then slumped by 57 bps to 4.42% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 4.42% in Q2 2026, 0.53% in Q1 2026, and 10.24% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.64 Bn | 1.16 Bn | 9.01% |
| 2 | RadNet | 5.80 Bn | 5.37 Bn | 88.08 Mn | 13.26% |
| 3 | Concentra Group Holdings Parent | 4.40 Bn | 4.26 Bn | 192.10 Mn | 19.73% |
| 4 | Privia Health | 2.61 Bn | 2.25 Bn | - | 0.25% |
| 5 | Pediatrix Medical | 2.20 Bn | 1.79 Bn | - | 25.41% |
| 6 | Fresenius Medical Care AG | 2.11 Bn | 1.41 Bn | 1.52 Bn | 17.70% |
| 7 | Progyny | 2.01 Bn | 1.77 Bn | 89.30 Mn | 12.61% |
| 8 | Surgery Partners | 1.87 Bn | 3.08 Bn | 622.10 Mn | 4.42% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.47 Bn | 41.94 Mn | 13.55% |
| 10 | Starling Oncology | 595.78 Mn | 554.69 Mn | 27.17 Mn | 6.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.42% |
| Mar 31, 2026 | -0.53% |
| Dec 31, 2025 | 10.24% |
| Sep 30, 2025 | 7.77% |
| Jun 30, 2025 | 7.01% |
| Mar 31, 2025 | -2.15% |
| Dec 31, 2024 | 10.31% |
| Sep 30, 2024 | 5.84% |
| Jun 30, 2024 | 7.33% |
| Mar 31, 2024 | 2.75% |
| Dec 31, 2023 | 5.82% |
| Sep 30, 2023 | 12.71% |
| Jun 30, 2023 | 3.94% |
| Mar 31, 2023 | 7.54% |
| Dec 31, 2022 | -2.19% |
| Sep 30, 2022 | 2.00% |
| Jun 30, 2022 | 3.20% |
| Mar 31, 2022 | 10.33% |
| Dec 31, 2021 | 0.92% |
| Sep 30, 2021 | -0.11% |